A. Choong

Interleukin-15 supports generation of highly potent clinical-grade natural killer cells in long-term cultures for targeting hematological malignancies.

G. Suck, S. Chu, M. Niam, 2011, Experimental hematology.

Clinical scale expansion of cytokine-induced killer cells is feasible from healthy donors and patients with acute and chronic myeloid leukemia at various stages of therapy.

G. Suck, S. Chu, M. Niam, 2011, Experimental hematology.

The anti-tumour activity of allogeneic cytokine-induced killer cells in patients who relapse after allogeneic transplant for haematological malignancies

W. Hwang, G. Suck, S. Chu, 2012, Bone Marrow Transplantation.

A phase I/II clinical trial of autologous cytokine-induced killer cells as adjuvant immunotherapy for acute and chronic myeloid leukemia in clinical remission.

C. Chuah, H. Ng, W. Hwang, 2012, Cytotherapy.